Global Azithromycin market, By Type (Oral, Injection, and Ophthalmic), Application (Bacterial Infections, Mycobacterium Avium Complex (MAC) Infection, and Others), Demographic (Children, Adult), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2030.
Azithromycin Market Analysis and Size
According to CDC estimates, around 2 million people got sick with COVID-19 each day during the first week of April 2019, which was approximately 60% higher than that for widespread STDs & HIV on average every year since 2013 (estimates). This scenario is expected to escalate further as there is no sign or indication yet that this pandemic will diminish soon. Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure, especially in developing countries such as India.
Data Bridge Market Research analyses that the azithromycin market, which was USD 6976.17 million in 2022, would rocket up to USD 10,706.23 million by 2030 and is expected to undergo a CAGR of 5.5% during the forecast period. "Oral" dominates the type segment of the Azithromycin market owing to the growing demand for quick and better therapeutic effects by drugs. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Azithromycin Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Oral, Injection, and Ophthalmic), Application (Bacterial Infections, Mycobacterium Avium Complex (MAC) Infection, and Others), Demographic (Children, Adult), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Pfizer Inc. (U.S), Mylan N.V. (U.S), Teva Pharmaceutical Industries Ltd. (Israel), Zydus Cadila (India), Akorn, Incorporated (U.S), Sandoz International GmbH (Germany), PLIVA (Croatia), Lupin (Maryland), Gland Pharma Limited (India), WOCKHARDT (India), Aurobindo Pharma (India), CSPC Pharmaceutical Group Limited. (China), Alembic Pharmaceuticals Limited (India), Betterway Pharmaceutical Group Ltd. (U.S), AnkeBio Co., Ltd (China), Zhejiang Nexchem Pharmaceutical Co., Ltd. (China), HEC Pharma Co., Ltd (China), Shanghai Shyndec Pharmaceutical Co., Ltd. (China), Qilu Pharmaceutical (Hainan) Co., Ltd. (China), Ercros S.A (Spain) and Infinity Laboratories Pvt. Ltd. (India)
|
|
Market Opportunities
|
|
Market Definition
Azithromycin is a macrolide antibiotic that is derived from erythromycin. It works by inhibiting the translocation step in protein synthesis by binding to ribosomal subunit in microorganisms which results in the inhibition of bacterial growth. It is used for the treatment of infections caused by bacteria such as bronchitis, pneumonia, sexually transmitted diseases, and other infection of the eye, skin, ear, and other respiratory conditions. It is also used to treat Mycobacterium Avium Complex (MAC) infection.
Global Azithromycin Market Dynamics
Drivers
- Increasing prevalence of respiratory tract infections
The global incidence of respiratory tract infections is high and is estimated to be around 5 billion cases per year. This number is expected to grow in the coming years due to the increasing population and changing lifestyle patterns. Azithromycin is a potent antibiotic that can effectively treat a wide range of respiratory tract infections, making it a preferred choice for physicians and patients. This factor is expected to drive the azithromycin market.
- Rising awareness about the benefits of Azithromycin
There has been increased awareness about the benefits of Azithromycin in recent years, thanks to various marketing campaigns by drug manufacturers and healthcare professionals. This has led to the rise in its use, both for prescription and over-the-counter purposes which helps in driving the market growth.
Opportunities
- Growing demand from emerging markets
The demand for Azithromycin is proliferating in emerging markets such as China, India, Brazil, and Mexico due to the increasing incidence of infectious diseases coupled with rising incomes and expanding healthcare infrastructure. This presents a huge opportunity for drug manufacturers operating in this market segment.
- Technological advancements
Azithromycin enjoys patent protection until 2019 across most major geographies including Europe and North America. However, this exclusivity period will expire soon which could lead to increased competition from generic players. This will provide beneficial opportunities for the azithromycin market growth.
Restraints/Challenges
- High cost of Azithromycin
The azithromycin market's growth may be hampered by tight government standards for approval of Azithromycin due to severe side effects.
The rise in the incidence of bacterial resistance due to long-term administration of Azithromycin and side effects associated with Azithromycin such as nausea, abdominal pain, diarrhea, irregular heartbeat, severe dizziness, and eye problems are the factors that will hinder the market growth and will further challenge the azithromycin market in the forecast period.
The azithromycin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the azithromycin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In April 2023, Zydus got approval for manufacturing Azithromycin as a treatment for infections like bronchitis, pneumonia and sexually transmitted diseases (STDs)
- In January 2020, Alembic Pharmaceuticals Ltd got FDA approval for its generic (ANDA) Azithromycin tablets USP 250 mg and 500 mg to be used for treating COVID-19
Global Azithromycin Market Scope
The azithromycin market is segmented based on type, application, demographic, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Type
- Oral
- Injection
- Ophthalmic
Application
- Bacterial Infections
- Mycobacterium Avium Complex (MAC) Infection
- Othersemographic
Demographic
- Children
- Adult
End User
- Clinic
- Hospital
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Azithromycin Market Regional Analysis/Insights
The azithromycin market is analyzed, and market size insights and trends are provided by country, product type, application, technology, and end-user, as referenced above.
The countries covered in the azithromycin market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, the Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
China dominates the azithromycin market because of its excellent healthcare facilities, the strong presence of major players, its extraordinary healthcare infrastructure, and its large population pool.
India is expected to witness significant growth during the forecast period of 2023 to 2030 due to the rising healthcare infrastructure, growing demand for advanced medical treatment drugs, large population pool, and increasing demand for quality healthcare in the region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The azithromycin market also provides you with detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the azithromycin market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the azithromycin market.
Competitive Landscape and Surgical Microscopes Market Share Analysis
The azithromycin market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points are only related to the companies focus on the azithromycin market.
Some of the major players operating in the azithromycin market are:
- Pfizer Inc. (U.S)
- Mylan N.V. (U.S)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Zydus Cadila (India)
- Akorn, Incorporated (U.S)
- Sandoz International GmbH (Germany)
- PLIVA (Croatia)
- Lupin (Maryland)
- Gland Pharma Limited (India)
- WOCKHARDT (India)
- Aurobindo Pharma (India)
- CSPC Pharmaceutical Group Limited. (China)
- Alembic Pharmaceuticals Limited (India)
- Betterway Pharmaceutical Group Ltd. (U.S)
- AnkeBio Co., Ltd (China)
- Zhejiang Nexchem Pharmaceutical Co., Ltd. (China)
- HEC Pharma Co., Ltd (China)
- Shanghai Shyndec Pharmaceutical Co., Ltd. (China)
- Qilu Pharmaceutical (Hainan) Co., Ltd. (China)
- Ercros S.A (Spain)
- Infinity Laboratories Pvt. Ltd. (India)
SKU-